Eline van Overbeeke

1.1k total citations
26 papers, 674 citations indexed

About

Eline van Overbeeke is a scholar working on Economics and Econometrics, General Health Professions and Pharmacology. According to data from OpenAlex, Eline van Overbeeke has authored 26 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 7 papers in General Health Professions and 6 papers in Pharmacology. Recurrent topics in Eline van Overbeeke's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Pharmaceutical industry and healthcare (6 papers) and Patient-Provider Communication in Healthcare (5 papers). Eline van Overbeeke is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Pharmaceutical industry and healthcare (6 papers) and Patient-Provider Communication in Healthcare (5 papers). Eline van Overbeeke collaborates with scholars based in Belgium, United States and United Kingdom. Eline van Overbeeke's co-authors include Isabelle Huys, Steven Simoens, Esther W. de Bekker‐Grob, Chiara Whichello, Jorien Veldwijk, Juhaeri Juhaeri, Bennett Levitan, Marc Dooms, Irina Cleemput and Rosanne Janssens and has published in prestigious journals such as Drug Discovery Today, Frontiers in Pharmacology and Value in Health.

In The Last Decade

Eline van Overbeeke

24 papers receiving 666 citations

Peers

Eline van Overbeeke
Elena Nicod United Kingdom
Jan Geißler United Kingdom
Anthony J. Hatswell United Kingdom
Kate Light United Kingdom
Lisa M. Holle United States
Sophie Beale United Kingdom
Lívia Lovato Pires de Lemos Brazil
Virginie Hivert France
Gurvaneet Randhawa United States
Michael J. Zoratti Canada
Elena Nicod United Kingdom
Eline van Overbeeke
Citations per year, relative to Eline van Overbeeke Eline van Overbeeke (= 1×) peers Elena Nicod

Countries citing papers authored by Eline van Overbeeke

Since Specialization
Citations

This map shows the geographic impact of Eline van Overbeeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eline van Overbeeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eline van Overbeeke more than expected).

Fields of papers citing papers by Eline van Overbeeke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eline van Overbeeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eline van Overbeeke. The network helps show where Eline van Overbeeke may publish in the future.

Co-authorship network of co-authors of Eline van Overbeeke

This figure shows the co-authorship network connecting the top 25 collaborators of Eline van Overbeeke. A scholar is included among the top collaborators of Eline van Overbeeke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eline van Overbeeke. Eline van Overbeeke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veldwijk, Jorien, Esther W. de Bekker‐Grob, Juhaeri Juhaeri, et al.. (2022). Suitability of Preference Methods Across the Medical Product Lifecycle: A Multicriteria Decision Analysis. Value in Health. 26(4). 579–588. 3 indexed citations
2.
Simoens, Steven, Liese Barbier, Rosanne Janssens, et al.. (2022). How to balance valuable innovation with affordable access to medicines in Belgium?. Frontiers in Pharmacology. 13. 960701–960701. 7 indexed citations
3.
Overbeeke, Eline van, et al.. (2021). Patient Preferences to Assess Value IN Gene Therapies: Protocol Development for the PAVING Study in Hemophilia. Frontiers in Medicine. 8. 595797–595797. 7 indexed citations
4.
Overbeeke, Eline van, Mondher Toumi, Hilde Stevens, et al.. (2020). Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions. Drug Discovery Today. 26(2). 399–415. 29 indexed citations
5.
Martin, Antony P., James E. Thomson, L Richardson, et al.. (2020). PRO124 Qualitative Research to Inform the Development of a Discrete Choice Experiment to Examine Preferences of People with Haemophilia for GENE Therapy. Value in Health. 23. S712–S712.
6.
Overbeeke, Eline van, Brett Hauber, Kathelijne Peerlinck, et al.. (2020). PBI55 Patient Preferences for GENE Therapy in Hemophilia: Results from the Paving Threshold Technique Survey. Value in Health. 23. S419–S420. 1 indexed citations
7.
Miljković, Nenad, Eline van Overbeeke, Brian Godman, et al.. (2020). Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages. Frontiers in Medicine. 7. 407–407. 7 indexed citations
8.
Whichello, Chiara, Irina Cleemput, Cathy Anne Pinto, et al.. (2020). An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?. Health Policy. 124(12). 1325–1332. 23 indexed citations
9.
Grine, Lynda, et al.. (2020). Improving Patient Involvement in the Lifecycle of Medicines: Insights From the EUPATI BE Survey. Frontiers in Medicine. 7. 36–36. 5 indexed citations
10.
Overbeeke, Eline van, et al.. (2020). Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives. Patient. 14(1). 119–128. 33 indexed citations
11.
Miljković, Nenad, Brian Godman, Eline van Overbeeke, et al.. (2020). Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals. Frontiers in Medicine. 7. 157–157. 22 indexed citations
12.
Overbeeke, Eline van, et al.. (2019). Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet Journal of Rare Diseases. 14(1). 99–99. 85 indexed citations
13.
Janssens, Rosanne, Isabelle Huys, Eline van Overbeeke, et al.. (2019). Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Medical Informatics and Decision Making. 19(1). 189–189. 37 indexed citations
14.
Whichello, Chiara, Eline van Overbeeke, Rosanne Janssens, et al.. (2019). Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US. Frontiers in Pharmacology. 10. 1009–1009. 19 indexed citations
15.
Overbeeke, Eline van, Rosanne Janssens, Chiara Whichello, et al.. (2019). Design, Conduct, and Use of Patient Preference Studies in the Medical Product Life Cycle: A Multi-Method Study. Frontiers in Pharmacology. 10. 1395–1395. 55 indexed citations
16.
Soekhai, Vikas, Chiara Whichello, Bennett Levitan, et al.. (2019). Methods for exploring and eliciting patient preferences in the medical product lifecycle: a literature review. Drug Discovery Today. 24(7). 1324–1331. 103 indexed citations
17.
Janssens, Rosanne, Eline van Overbeeke, Kim Pauwels, et al.. (2018). Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice. Frontiers in Medicine. 5. 285–285. 12 indexed citations
18.
Overbeeke, Eline van, Chiara Whichello, Rosanne Janssens, et al.. (2018). Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discovery Today. 24(1). 57–68. 72 indexed citations
19.
Soekhai, Vikas, Chiara Whichello, Bennett Levitan, et al.. (2017). Compendium Of Methods For Measuring Patient Preferences In Medical Treatment. Value in Health. 20(9). A684–A685. 6 indexed citations
20.
Overbeeke, Eline van, et al.. (2017). Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists. BioDrugs. 31(5). 447–459. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Nicod Breakdown of academic impact, for papers by Jan Geißler Breakdown of academic impact, for papers by Anthony J. Hatswell Breakdown of academic impact, for papers by Kate Light Breakdown of academic impact, for papers by Lisa M. Holle Breakdown of academic impact, for papers by Sophie Beale Breakdown of academic impact, for papers by Lívia Lovato Pires de Lemos Breakdown of academic impact, for papers by Virginie Hivert Breakdown of academic impact, for papers by Gurvaneet Randhawa Breakdown of academic impact, for papers by Michael J. Zoratti
Rankless by CCL
2026